After a virus has entered the central nervous system (CNS) there are several possible outcomes, depending on the interaction between the virus and the host immune system (59) . Fulminate encephalitis results when virus spreads too rapidly to be contained by an unprimed or ineffectual immune system. At the opposite extreme, a virus may cause minimal cytopathologic change and establish a persistent infection (49) . Although the CNS has historically been considered an immunologically privileged site, viral infections can nevertheless be controlled through antibody-or cell-mediated mechanisms (41, 50, 52) . The mechanisms of T-cell-mediated clearance are poorly understood but are likely to differ from those employed in the periphery, because the CNS lacks lymphatic ducts and constitutive major histocompatibility complex class I (MHC-I) expression and its vascular architecture imposes constraints on access by leukocytes and soluble immune mediators (10) . Furthermore, as most CNS neurons are terminally differentiated, nondividing cells, clearance of virus by a noncytopathic mechanism is advantageous. Clearly, a detailed understanding of the immune mechanisms responsible for viral clearance in the CNS is needed in order to develop therapeutic strategies to limit or prevent neuronal damage as a result of acute and chronic viral encephalitides.
Mouse hepatitis virus (MHV), a member of the coronavirus family, has been used to study virus-induced neurological diseases. In the murine model, the outcome of infection depends on the virus strain and route of inoculation as well as on host responses and genetic susceptibility (9) . While (51, 62, 63, 68, 71) compromise the blood-brain barrier, confound studies of viral spread, and influence the entry of immune cells or soluble mediators into the CNS. Conversely, intranasal inoculation with hepatotropic strains of MHV, which are normally spread by a fecal-oral route, cause hepatitis which can be fatal and might complicate studies of the immune response to the CNS infection (3, 9) . Neurovirulent strains produce an acute and often fatal encephalitis with extensive neuronal involvement, whereas neuroattenuated strains spread only slowly in neurons and generally infect glia, with attendant chronic white matter disease (7, 15, 17, 33) . In the study of viral clearance from neurons, it is advantageous to have a model in which neurons are infected preferentially but in which fatal encephalitis does not ensue. The recently isolated JHM-CC small-plaque mutant (27) and the V5A13.1 deletion mutant (13) partially fulfill these requirements, but these MHV variants appear to persist in white matter (12a, 27) . These studies underscore the need for a model of MHV clearance from the CNS in which the variables responsible for clearance can be more easily isolated and identified. In such a model, clearance would ideally be rapid and complete, with minimal white matter degeneration.
Although data derived from available models has implicated both CD4+ and CD8+ cells in clearing MHV from the CNS (48, 63, 68, 71) , the mechanisms underlying this process are enigmatic. Fatal MHV encephalitis can be prevented by adoptive transfer of CD4+ cells, without significantly decreasing viral load (62) . Conversely, immune-competent mice inoculated with MHV (JMHV-DS) intracerebrally succumb to the infection even though viral titers in the brain have declined to undetectable levels (67) . Several reports have focused attention on cytokines as possible mediators of MHV clearance (48, 63, 66, 71) , yet in part because of technical limitations, there is a lack of studies involving direct measurements of cytokines induced in the CNS during clearance of MHV. One impediment to direct measurements of cytokines in serum or tissue is that the assays employed may be too insensitive to detect small changes in cytokine levels (61) . Nevertheless, gamma interferon (IFN-y) has been strongly implicated in viral clearance on the basis of indirect indices of cytokine induction (43, 54, 61, 66) . Moreover, MHV infection differentially regulates spleen cell production of IFN-y and that of interleukin-2 (IL-2), IL-3, and IL-4 (lOa, 37). It is not known if there is a similar modulation of the immune cells infiltrating MHV-infected brain tissue in vivo, but T cells derived from the brains of infected mice produce IFN--y and IL-2 after stimulation in vitro (66) . There is a complex interregulation of these and other cytokines which are probably operating together as a network during viral clearance (5, 54) . A thorough appreciation of the operation of this network during clearance of viruses from the CNS will likely require analysis of the temporal sequence of induction for each of the cytokines involved in the clearance process.
In this report, we describe a mouse model developed to overcome some of the limitations to studying MHV clearance from the CNS. This model utilizes intranasal infection with an MHV variant (OBLV60) which is highly neurotropic yet manifests distinct and limited regional localization within the brain, low mortality, and no paralytic sequela. We have used this model to assess the temporal pattern of induction of 10 different cytokine genes during viral clearance. We further correlate the pattern of cytokine gene induction with macrophage and T-cell infiltration, gliosis, and the expression of immune accessory molecules of MHC-I and MHC-II.
MATERIALS AND METHODS
Virus and infection protocol. Virus stocks were grown in OBL-21a cells (55) from a 60-day isolate designated OBLV60, as described previously (19) . MHV4 was propagated in Saccells (19) . Mice (7 to 13 weeks old) were inoculated with 1,000 PFU of OBLV60 intranasally and then killed by exsanguination under methoxyflurane or ketamine anesthesia. Shaminoculated mice served as controls. Virus titers in tissue homogenates or cell supernatants were determined by plaque assay on DBT cells, as described previously (13) . For studies of virus-induced syncytia, the hypothalamic neuron cell line, GT1-7 (gift of P. J. Mellon) (47) Immunohistochemical analyses for GFAP, F4/80, and nonphosoneurofilament protein were performed on tissues fixed in zinc formalin (Anatech) which were then embedded in paraffin. Staining for CD4, CD8, H-2 monotyptic, or JAd cells was performed on frozen sections fixed in acetone or ethanol at -20°C. Ethanol gave superior fixation but increased background staining compared with acetone fixation. Acetone-fixed frozen sections were used for F4/80 and H-2Kd staining. When using these two antibodies, fixation in 2% paraformaldehyde improved morphology without diminishing staining intensity. Aldehyde fixation of tissue prior to immunostaining with F4/80 necessitated treatment with trypsin to reveal epitopes. Normal goat serum, avidin/biotin (Vector Laboratories), and 1% hydrogen peroxide in methanol were used as needed to block nonspecific staining. The ABC elite staining system was used according to the manufacturer's instructions (Vector Laboratories). Diaminobenzidine was used as a chromogen, and all slides were counterstained with hematoxylin.
When combining immunohistochemical analysis to identify neurons with in situ hybridization for viral RNA, the above procedure was modified. Immunohistochemical analysis for nonphosoneurofilament proteins preceded in situ hybridization and utilized a buffer intended to reduce RNase activity and loss of in situ signal (26) . The immunohistochemical analysis was performed in 0.05 M Tris (pH 7.6) containing 1.5% (wt/vol) NaCl. During incubations with antibodies, 0.2 mg of tRNA per ml-5,000 U of sodium heparin per ml was included in the buffer. After applying diaminobenzidine, slides were dehydrated by passage through alcohol and stored for up to 48 h prior to undergoing the in situ procedure.
RNase protection assay. Total RNA was isolated from mouse brain tissues by extraction in guanidinium thiocyanate followed by centrifugation through 5.7 M CsCl (56) . The RNase protection assay for quantitation of cytokine mRNA was performed exactly as described previously (25) . subclones in pGEM-4 (described in a previous report [25] ) were linearized with EcoRI and were used as a set for T7-directed synthesis of 32P-labeled antisense RNA probes.
The hybridization reactions (5 ,ug of target RNA), RNase treatments, isolation of protected RNA duplexes, and resolution of protected probes by denaturing polyacrylamide gels were as described previously (25) . Within each assay, control groups included the probe set hybridized to tRNA only and to tRNA plus an equimolar pool of synthetic-sense RNAs complementary to the probe set. Dried gels were placed on film (XAR; Kodak) with intensifying screens and were developed for various periods of time at -70°C.
RESULTS
OBLV60 is a variant of MHV4 which was isolated for its ability to grow in a transformed neuron-like cell line (OBL21a) derived from the mouse olfactory bulb (19) . This virus grows to high titer in OBL-21a cells and can persistently infect these cells without causing cytopathic effects (19) . We investigated the ability of this virus to grow in a transformed neuron cell line (GT1-7) derived from the mouse hypothalamus (47) . Although OBLV60 grew to higher titers in these cells than did MHV4, syncytia were evident in MHV4-infected cultures, whereas no syncytia were observed in OBLV60-infected cultures ( Fig. 1) . By 48 h after infection, few intact cells remained in the MHV4-infected cultures. In OBLV60-infected cultures, cells were reduced by 50 to 60% at this time, but no syncytia were observed. These data indicate that OBLV60 can infect neurons in vitro yet has reduced cytopathicity relative to the parental wild-type virus.
We therefore assessed the ability of OBLV60 to infect neurons in vivo by inoculating BALB/c mice with the virus intranasally and using in situ hybridization to determine the cellular localization of viral RNA. Most of the infected cells at 5 and 7 days postinoculation were found in the olfactory bulb and adjacent regions (Fig. 2) . The glomerular and mitral layers were prominently involved, but infected cells were only occasionally seen in the internal granular layer. There was also frequent infection in the region of the ventral tegmentum. Infection of neurons in the olfactory bulb and ventral tegmentum was confirmed with in situ hybridization for viral RNA performed in conjunction with immunohistochemical analysis for neurofilament protein (data not shown). Infected cells were occasionally seen elsewhere in the brain, including the habenula, septum, and brain stem; the hippocampus and cerebellum were consistently spared. Although the pattern of infection indicated predominant involvement of neurons, some glia may have also been infected.
Whereas intranasal inoculation with MHV4 usually resulted in fatal encephalitis as a result of widespread dissemination of infection in the brain (13) , mice consistently recovered from infection with OBLV60. We therefore examined whether the virus was being cleared from the brains of OBLV60-infected mice during clinical recovery. Because in situ hybridization had revealed a predilection for the olfactory bulb, we compared viral titers in the olfactory bulb with titers in the remainder of the brain (Fig. 3A) . Virus grew preferentially in the olfactory bulb, with peak titers in the olfactory bulb and the remainder of the brain occurring at 5 days postinfection. Titers declined rapidly to below detectable limits by 11 days. In situ hybridization, which detects viral RNA, was used to confirm that clearance was complete by 11 days postinfection (Fig. 4A) been immune suppressed by the administration of cyclophosphamide at the time of inoculation (Fig. 4B) . These immunosuppressed mice manifested signs of encephalitis and were moribund by 15 days postinfection, whereas infected immunocompetent controls were clinically normal at this time. Infected cells could not be found in the brains of initially immunocompetent mice which were then immunosuppressed with a single dose of cyclophosphamide at 24 days postinfection and evaluated at 31 days postinfection (Fig. 4C) . These data further confirm that clearance was complete. Furthermore, we have observed no symptoms of paralysis in any of the immunecompetent infected mice, including a group of seven mice observed for a period of more than 1 year.
The role of T cells in mediating clearance was investigated by infecting BALB/c nu/nu (athymic nude) mice with OBLV60
and assessing viral clearance with plaque assays and in situ hybridization ( Fig. 3B and 5 ). These mice failed to clear the virus and were moribund between 11 and 16 days postinfection. Infected neurons could be demonstrated in these mice in many regions including the cerebellum, which was not infected in immune-competent mice (Fig. 6) . Thus, T cells were important in clearing the virus from the CNS. To determine the relative contribution of T-cell subsets in this process we selectively depleted mice of CD4+ cells, CD8+ cells, or both and then infected these mice with OBLV60. In situ hybridization revealed that both T-cell subsets are necessary for optimal clearance, since viral RNA could be detected at 11 days postinfection in the brains of mice depleted of either CD4+ or CD8+ cells (Fig. 7) . Infection with OBLV60 appeared to result in loss of mitral cells in immunocompetent mice as well as in mice depleted of CD4+ or CD8+ cells (Fig. 8) . Simultaneous depletion of both CD4+ and CD8+ T-cell subsets resulted in dissemination of virus throughout numerous brain regions, including the cerebellum (Fig. 7) . Virus could be detected by plaque assay from the brains of CD4+ cell-depleted mice but not from the brains of CD8+ cell-depleted mice at 16 days postinoculation (Table 1) . Virus persisted in the brains, but not in the olfactory bulbs, of CD4+ cell-depleted mice at 31 days postinfection, yet these mice appeared normal clinically. To investigate the mechanism by which T cells mediated clearance, we performed immunohistochemical analyses for CD4+ and CD8+ cells on OBLV60-infected brain tissue at 6 days postinfection, when T-cell-mediated clearance was maximal (Fig. 9) . In uninfected brain tissues (Fig. 9B and D) , only one or two cells expressing either marker were observed in each sagittal section, usually in the choroid plexus or ependyma. In contrast, brain tissue from OBLV60-infected BALB/c mice consistently had numerous CD4+ (Fig. 9A) and CD8+ (Fig. 9C ) cells in the olfactory bulb and the brain stem. The common appearance of these cells near vessels indicated they had probably infiltrated into the brain from the bloodstream. Whereas most CD4+ and CD8+ cells were predominantly found in regions which were infected, there was a general increase in these cells near vessels and in the choroid plexus, ependyma, and meninges. Occasionally, stained cells were found in regions not usually infected, such as the hippocampus. Cells expressing CD8 were more widespread than those expressing CD4. In the olfactory bulb, both CD4+ and CD8+ cells were observed in the internal granule layer (Fig.  9A and C) , even though this layer has very few infected cells compared with the mitral or glomerular layers (Fig. 2) . The role of these lymphocytes in the internal granule layer is undetermined; a mild necrosis in this region is observed even when mice are depleted of either CD4+ or CD8+ cells (Fig. 8) .
Surprisingly, in nude mice CD4+ cells were observed in the olfactory bulb and surrounding meninges (data not shown). CD4+ cells were very rare outside the olfactory bulb or immediately adjacent areas in nude mice. Cells staining for the CD8 marker could also be found in the olfactory bulb region of nude mice, although they were rare in comparison to their frequency in the olfactory bulbs of infected immune-competent mice. Unlike infected immunocompetent mice, the brains of infected nude mice usually had no CD8+ cells outside the olfactory bulb region.
Immunohistochemical analysis with MAb F4/80 (53) was used to determine if macrophages and activated microglia were present during clearance (Fig. 9E, F, and G) . Macrophages were observed in infected regions, and there was an increased staining intensity even in regions where infected cells were uncommon ( 
Days Post Infection
It has been proposed that cytokines mediate clearance of viruses from the CNS (54). In the brain, cytokines may be produced by infiltrating immune cells, microglia, or astrocytes (5) . The infiltration of macrophages and CD4+-and CD8+-positive cells, as well as the activation of microglia and astrocytes, all of which occurred during OBLV60 clearance, prompted us to investigate cytokine induction during viral clearance. For this purpose we used an RNase protection assay to measure cytokine transcripts for IL-lot, IL-11, IL-2, IL-3, IL-4, IL-5, IL-6, tumor necrosis factor alpha (TNF-ot), TNF-P, and IFN-y. In the brains of BALB/c mice there was an abrupt increase in mRNA for TNF-ot, IL-lot and -P, IL-6, and INF--y, which corresponded to the time of maximal clearance (Fig. 10) . These cytokines returned to baseline as the virus was cleared. In the brains of nude mice 6 days after inoculation, these cytokines were similarly induced, with the exception of IFN-y which was barely detectable (Fig. 11) (Fig. 3B and 5) , and their cytokine transcripts remained elevated at 11 days (Fig. 11) . During clearance of viral infection, elements of the immune system work in concert. The presence of CD8+ cell infiltrates in infected brains suggested that CTL-mediated events may be operating within the CNS during clearance of OBLV60 infection. An important component of CTL-mediated immunity is the expression of MHC-I molecules which is normally very low in the brain. Given the induction of IFN--y and TNF-o during clearance of OBLV60 and the known role of these cytokines in upregulating MHC-I expression on neural cells (5), we investigated whether MHC-I expression was induced concomitant with the clearance of OBLV60. Immunohistochemical analysis with an antibody against H-2 monotypic antigen of MHC-I demonstrated a large increase in MHC-I expression in the brains of mice 6 days after infection with OBLV60 (data not shown). There was a generalized increase in the staining of vessels throughout the brain, but this was particularly evident in infected regions like the olfactory bulb. Some of the intense staining in the olfactory bulb was not associated with vessels. Staining with an H-2K"-specific antibody gave similar results, although staining extraneous to vessels was more evident, especially in the outer layers of the olfactory bulb, including the nerve fiber layer (Fig. 12) . Staining remained increased in the olfactory bulb 26 days after infection ( Table 2 ). There were similar increases in H-2Kd in the brains of nude mice 6 days after infection. By 11 days postinfection, H-2K" staining was found throughout the brains of nude mice, including the hippocampus, although the most intense staining was in the olfactory bulb which had been infected the longest (Table 2) . In situ hybridization revealed that many brain regions were infected at this time, although the hippocampus was usually uninfected or only sparsely infected (Fig. 5) .
Immunohistochemical analyses for MHC-II (iMd) of brain tissues from BALB/c mice at 6 days postinfection revealed a small number of positive cells which were clustered in the glomerular and external plexiform layers of the olfactory bulb ( Table 2 ). The morphology of these cells was consistent with that of lymphocytes although they were slightly less common, and their infiltration apparently less extensive, than cells staining for either CD4 or CD8.
DISCUSSION
We have developed an in vivo mouse model, utilizing infection with the OBLV60 variant of MHV, which has several features that make it advantageous for the study of clearance mechanisms. (i) The virus is neuroinvasive: we obtain consistent and reproducible CNS infection with OBLV60 by intranasal administration. This obviates the localized CNS trauma associated with intracranial inoculations. (ii) The virus is neuronotropic but is neuroattenuated: OBLV60 infects neurons and grows to high titers in the olfactory bulb, yet there is virtually no mortality in mice given 1,000 PFU intranasally. Thus, the clearance of OBLV60 from neurons can be investigated with little risk of mice dying of encephalitis. (iii) Clearance of virus occurs rapidly and is complete by 11 days after inoculation. Although many strains of MHV produce paralytic disease after recovery from the acute infection (12, 16, 38, 40) , this is not observed with OBLV60.
Using this model we have determined that both CD4+ and CD8+ subsets play an important role in clearing OBLV60 from the brain. Normal BALB/c mice clear virus from the brain by 11 days, but nude mice are unable to do so and inevitably succumb to encephalitis. Our data are consistent with those of previous studies using other strains of MHV which have demonstrated the importance of T cells in mediating clearance or protecting mice from MHV-induced encephalitis (48, 63, 68, 71) . Although the mechanism of clearance was not established by these prior studies, CTL-mediated lysis of infected cells has been suggested (71) . Our data, as well as several prior studies (63, 67, 68, 71) , could be interpreted to support this hypothesis. We found that clearance of OBLV60 is delayed in mice depleted of CD8+ T cells, and mice infected with OBLV60 had CD8+ cell infiltration and upregulation of MHC-I in infected regions of their brains at a time which coincided with maximal viral clearance. Nevertheless, if immunocompetent mice cleared the virus primarily through CTL-mediated lysis of infected cells then, given the large number of infected cells in the olfactory bulb, we would have expected to observe considerably more destruction in the olfactory bulbs of these mice during clearance than in the olfactory bulbs of mice depleted of CD8+ cells. The degree of cell destruction did not appear to be reduced in olfactory bulbs taken from infected mice depleted of CD8+ cells compared with those of infected controls. Therefore, CD8+ cells may be operating to clear virus through nonlytic mechanisms. Ultimately, CD8+ cells may not be strictly essential for clearance because all mice depleted of these cells cleared the virus by 16 days postinfection.
In contrast, mice depleted of CD4+ cells were persistently infected and virus could be recovered from their brains at 31 days postinfection. Previous studies have demonstrated the importance of CD4+ cells in clearance of MHV from the mouse CNS (48, 63, 68) . One mechanism suggested is that CD4+ cells may provide help to CD8+ effectors, and it is presumably these CD8+ effectors which clear the virus through lysis of infected cells. Alternatively, CD4+ cells may release Mild necrosis and mononuclear cell infiltration are seen in the internal granule layer. ep, external plexiform; m, mitral; ip, internal plexiform; g, internal granule layer. Hematoxylin and eosin stain. Original magnification, x200.
cytokines which act on infected cells to mediate clearance (48, OBLV6O. We found induction of IL-la, IL-1,B, IL-6, TNF-a 66). and IFN-y in immune-competent mice at 6 days postinfection Whereas numerous cytokines have been reported to be during the period of maximal clearance. In nude mice a similar induced by MHV (20, 29, 31, 37, 43, 44, 48, 58, 61, 65, 66) studies, it will be useful to design an RNase protection assay to detect additional transcripts for antiviral cytokines, such as IL-12, IFN-1, and granulocyte-macrophage colony-stimulating factor, and to correlate the observed message levels with cytokine concentrations in tissues.
Both CD4+ and CD8+ cells can produce IFN-y in response to MHV (48, 71) . Whereas IFN-y production by either subset would be consistent with our findings in nude mice, CD4+ cells appear to play a predominant role because mice depleted of this subset become persistently infected. Although CD4 and CD8 immunoreactive cells were found in the olfactory bulbs of nude mice infected with OBLV60, these cells were ineffective in mediating clearance, perhaps because these T cells were too scarce, immature, or had not undergone clonal expansion in response to the virus (32, 35) .
The induction of mRNA for IL-1, IL-6, and TNF-ot at 6 days was comparable in nude mice and immunocompetent BALB/c mice. In the CNS, these and other cytokines mediate communication between resident and infiltrating cells through a complex network in which immune accessory molecules such as MHC and cytokine expression are interregulated in response to infection. As an element in this network, TNF-ox may be acting synergistically with IFN--y to mediate clearance (14, 57, 70) . IFN-,y can also act synergistically with IL-1 or TNF to induce nonimmune cells to produce manganese superoxide dismutase which protects against oxygen-free radicals (23, 69) . Considering that IL-1, TNF-a, and IL-6 are known mediators of CNS damage (5), the coinduction of IFN-y with these (21, 24, 34) , and IL-6 production is not exclusively under transcriptional control (29) . Therefore, whereas our RNase protection assay gave an indication of which cytokines were induced during infection, the activity of these proteins may also be modulated by posttranscriptional events.
In vitro, MHC-I expression in cells derived from the brain can be increased, decreased, or unchanged by infection with MHV, depending on cell type, MHC haplotype, and host species (30, 46, 64) . Induction of MHC-I mRNA has been reported in mouse brain tissue after infection with MHV-A59 (22) . Consistent with these RNA data, we found by immunostaining that MHC-I was induced in the brain by infection with OBLV60. Considered in the context of cytokine induction in our mice, several conclusions can be put forth from these data. (i) Although the greatest increase in MHC-I was in infected regions, the increased immunostaining in adjacent uninfected regions suggests that a soluble factor(s) mediates induction.
(ii) Although IFN-y has been proposed as a mediator of MHC-I upregulation in response to MHV infection (59, 66, 71) , we found that MHC-I induction by OBLV60 was similar in normal and nude mice and hence was not quantitatively dependent on IFN-y induction. The suggestion that a soluble factor like TNF may mediate MHC-I induction on glia (64) is consistent with our finding that mRNA for TNF-ot was comparably induced in normal and nude mice. IFN-at/I can also induce MHC-I expression in the periphery (42) , and circulating levels of IFN-od/3 are increased after infection with MHV (20) . (iii) Immunostaining for MHC-I remained elevated at least 15 days after the virus was cleared, perhaps because mRNA levels for MHC remained elevated as indicated by studies with MHV-A59 (22) . (iv) Upregulation of MHC-I in the nerve fiber layer of the olfactory bulb suggests that some neurons may be capable of MHC-I antigen presentation, as suggested by recent in vitro and in vivo studies (11, 28, 45) .
Whereas an understanding of the exact mechanism by which OBLV60 is cleared will require further study, on the basis of our data and hypotheses derived from studies with other viruses, the following scheme is proposed. OBLV60 initially infects the nasal mucosa and enters the olfactory bulb by axonal transport along the olfactory nerve (1, 2, 39 ). Primary immune activation likely occurs in cervical lymph nodes (4, 10) or nasal-associated lymphatic tissue (36) , and between 3 and 6 days after infection monokines are produced by invading macrophages, endothelial cells, and glia (5, 6, 8, 18, 29) . T cells infiltrate the brain by 6 days, perhaps because of the expression of adhesion molecules on endothelial surfaces induced by TNF-c and IL-1 (60) . Expression of MHC-I on the endothelium may also be important for extravasation of CD8 T cells (30, 59) , and parenchymal MHC-I expression could activate T cells and focus antiviral cytokine production at sites of infection (54) . While some neurons might be cleared of virus, others could be killed either by the immune response or by the cytopathic effects of the virus itself. Additional studies are needed to determine which of these mechanisms predominates. 
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